[ad_1]
Too Long; Didn’t Read
As companies embrace GenAI, what is the balance between flexibility and risk? Should we be building our own GenAI solutions in-house (and can we?), or is it safer to be buying off-the-shelf products from established vendors? As things change so rapidly, are we at risk of lock-in at the pace of tech advances?
[ad_2]
Source link